Literature DB >> 28033687

Thrombospondin-1 gene polymorphism is associated with estimated pulmonary artery pressure in patients with sickle cell anemia.

Seethal A Jacob1, Enrico M Novelli2,3, Jeffrey S Isenberg3,4, Melanie E Garrett5, Yanxia Chu4, Karen Soldano5, Kenneth I Ataga6, Marilyn J Telen7, Allison Ashley-Koch5, Mark T Gladwin3,4, Yingze Zhang3,4,8, Gregory J Kato2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28033687      PMCID： PMC5303556          DOI： 10.1002/ajh.24635

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  9 in total

1.  Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner.

Authors:  Jeff S Isenberg; Lisa A Ridnour; Elizabeth M Perruccio; Michael G Espey; David A Wink; David D Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-06       Impact factor: 11.205

2.  Plasma thrombospondin-1 is increased during acute sickle cell vaso-occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic rates.

Authors:  Enrico M Novelli; Gregory J Kato; Margaret V Ragni; Yingze Zhang; Mariana E Hildesheim; Mehdi Nouraie; Suchitra Barge; Michael P Meyer; Andrea Cortese Hassett; Victor R Gordeuk; Mark T Gladwin; Jeffrey S Isenberg
Journal:  Am J Hematol       Date:  2012-02-08       Impact factor: 10.047

Review 3.  Cardiovascular complications and risk of death in sickle-cell disease.

Authors:  Mark T Gladwin
Journal:  Lancet       Date:  2016-06-18       Impact factor: 79.321

4.  Mechanism of CD47-induced alpha4beta1 integrin activation and adhesion in sickle reticulocytes.

Authors:  Julia E Brittain; Jaewon Han; Kenneth I Ataga; Eugene P Orringer; Leslie V Parise
Journal:  J Biol Chem       Date:  2004-07-29       Impact factor: 5.157

5.  Thrombospondin-1 and L-selectin are associated with silent cerebral infarct in children with sickle cell anaemia.

Authors:  Lisa M Faulcon; Zongming Fu; Pratima Dulloor; Emily Barron-Casella; William Savage; Jacky M Jennings; Jennifer E Van Eyk; Michael Debaun; James F Casella; Allen Everett
Journal:  Br J Haematol       Date:  2013-05-14       Impact factor: 6.998

6.  Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling.

Authors:  Jeff S Isenberg; Martin J Romeo; Christine Yu; Christine K Yu; Khauh Nghiem; Jude Monsale; Margaret E Rick; David A Wink; William A Frazier; David D Roberts
Journal:  Blood       Date:  2007-09-21       Impact factor: 22.113

7.  Cellular, pharmacological, and biophysical evaluation of explanted lungs from a patient with sickle cell disease and severe pulmonary arterial hypertension.

Authors:  Natasha M Rogers; Mingyi Yao; John Sembrat; M Patricia George; Heather Knupp; Mark Ross; Maryam Sharifi-Sanjani; Jadranka Milosevic; Claudette St Croix; Revathi Rajkumar; Maria G Frid; Kendall S Hunter; Luciano Mazzaro; Enrico M Novelli; Kurt R Stenmark; Mark T Gladwin; Ferhaan Ahmad; Hunter C Champion; Jeffrey S Isenberg
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

8.  Factors associated with survival in a contemporary adult sickle cell disease cohort.

Authors:  Hany Elmariah; Melanie E Garrett; Laura M De Castro; Jude C Jonassaint; Kenneth I Ataga; James R Eckman; Allison E Ashley-Koch; Marilyn J Telen
Journal:  Am J Hematol       Date:  2014-02-21       Impact factor: 10.047

9.  Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom.

Authors:  Mark T Gladwin; Robyn J Barst; J Simon R Gibbs; Mariana Hildesheim; Vandana Sachdev; Mehdi Nouraie; Kathryn L Hassell; Jane A Little; Dean E Schraufnagel; Lakshmanan Krishnamurti; Enrico Novelli; Reda E Girgis; Claudia R Morris; Erika Berman Rosenzweig; David B Badesch; Sophie Lanzkron; Oswaldo L Castro; James G Taylor; Jonathan C Goldsmith; Gregory J Kato; Victor R Gordeuk; Roberto F Machado
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240
  9 in total
  5 in total

1.  Regulation of Cellular Redox Signaling by Matricellular Proteins in Vascular Biology, Immunology, and Cancer.

Authors:  David D Roberts; Sukhbir Kaur; Jeffrey S Isenberg
Journal:  Antioxid Redox Signal       Date:  2017-09-08       Impact factor: 8.401

Review 2.  Matricellular protein thrombospondin-1 in pulmonary hypertension: multiple pathways to disease.

Authors:  Natasha M Rogers; Kedar Ghimire; Maria J Calzada; Jeffrey S Isenberg
Journal:  Cardiovasc Res       Date:  2017-07-01       Impact factor: 10.787

3.  THBS1 (thrombospondin-1).

Authors:  Jeffrey S Isenberg; David D Roberts
Journal:  Atlas Genet Cytogenet Oncol Haematol       Date:  2020

4.  Genetic Modifiers at the Crossroads of Personalised Medicine for Haemoglobinopathies.

Authors:  Coralea Stephanou; Stella Tamana; Anna Minaidou; Panayiota Papasavva; Marina Kleanthous; Petros Kountouris
Journal:  J Clin Med       Date:  2019-11-09       Impact factor: 4.241

5.  Association of THBS1 genetic variants and mRNA expression with the risks of ischemic stroke and long-term death after stroke.

Authors:  Changying Chen; Xuemei Chen; Siyuan Yang; Qingqing Li; Zhanyun Ren; Lu Wang; Yuzhang Jiang; Xincheng Gu; Fangyuan Liu; Jialing Mu; Lihua Liu; Yi Wang; Junrong Li; Yanhua Yu; Jun Zhang; Chong Shen
Journal:  Front Aging Neurosci       Date:  2022-09-23       Impact factor: 5.702
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.